Celldex Therapeutics to Present Clinical Results at 2017 ASCO Annual Meeting
May 17, 2017 21:02 pm UTC| Business
HAMPTON, N.J., May 17, 2017 -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that clinical results from the single-agent cohort of the Phase 2 study of glembatumumab vedotin in patients with metastatic...
Celldex Therapeutics to Present Clinical Results at 2017 ASCO Annual Meeting
May 17, 2017 21:02 pm UTC| Business
HAMPTON, N.J., May 17, 2017 -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that clinical results from the single-agent cohort of the Phase 2 study of glembatumumab vedotin in patients with metastatic...
May 17, 2017 21:01 pm UTC| Business
Hoersholm, Denmark, May 17th, 2017 - Medical Prognosis Institute A/S ("MPI") today announced that the previously warranted abstract with DRP data on epirubicin for breast cancer has been published electronically on the...
SPAR Group Announces Departure of CEO
May 17, 2017 21:01 pm UTC| Business
WHITE PLAINS, N.Y., May 17, 2017 -- SPAR Group, Inc. (Nasdaq:SGRP), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced that, Scott...
SPAR Group Announces Departure of CEO
May 17, 2017 21:01 pm UTC| Business
WHITE PLAINS, N.Y., May 17, 2017 -- SPAR Group, Inc. (Nasdaq:SGRP), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced that, Scott...
Intercept to Present at Upcoming Conferences
May 17, 2017 21:01 pm UTC| Business
NEW YORK, May 17, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases,...
Intercept to Present at Upcoming Conferences
May 17, 2017 21:01 pm UTC| Business
NEW YORK, May 17, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases,...